Cantitate/Preț
Produs
Total produse
Vezi coșul
Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside de Naga Chalasani

Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside

Editat de Naga Chalasani, Gyongyi Szabo
en Limba Engleză Hardback – 18 dec 2015
This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and nonalcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies.
Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 57462 lei  39-44 zile
  Springer International Publishing – 27 mar 2019 57462 lei  39-44 zile
Hardback (1) 70076 lei  39-44 zile
  Springer International Publishing – 18 dec 2015 70076 lei  39-44 zile

Preț: 70076 lei

Preț vechi: 73765 lei
-5% Nou

Puncte Express: 1051
Preț estimativ în valută:
13412€ • 14149$ • 11177£

Carte tipărită la comandă

Livrare economică 30 decembrie 24 - 04 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319205373
ISBN-10: 3319205374
Pagini: 478
Ilustrații: XVI, 372 p. 47 illus., 36 illus. in color.
Dimensiuni: 178 x 254 x 22 mm
Greutate: 1.12 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Public țintă

Professional/practitioner

Cuprins

Epidemiology and Risk Factors for Alcoholic Liver Disease.- Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver Disease.- Pathogenesis of Alcoholic Liver Disease.- Pathogenesis of NAFLD and NASH.- Animal Models of Alcoholic Liver Disease.- Animal Models of Nonalcoholic Fatty Liver Disease.- Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver Disease.- Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver Disease.- Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History.- Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver Disease.- Diagnostic Considerations and Clinical Endpoints for Nonalcoholic Steatohepatitis.- Pathology of Alcoholic and Non-Alcoholic Fatty Liver Disease.- Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver Disease.- Hepatic and Extra-Hepatic Malignancies in NAFLD.- Treatment of Alcoholic Liver Disease Including Emerging therapies, Novel targets and Liver transplantation.- Current and Emerging Therapies for Non-Alcoholic Fatty Liver Disease.- Nonalcoholic Fatty Liver Disease in Children.

Recenzii

“The purpose is to serve as a review of both mechanisms of liver disease. The book is meant to compare the two unique diseases, which share several mechanisms. … The book summarizes current knowledge and contains updates on recent research. … This is a high quality resource on the topic of alcoholic and nonalcoholic fatty liver disease, providing an in-depth discussion of the mechanisms … .” (Ryan R. Sefcik, Doody's Book Reviews, June, 2016)

Notă biografică

Drs. Chalasani and Szabo are senior investigators in the field of fatty liver disease and have had extensive federal funding to investigate these areas. They both hold leadership positions and are recognized as experts in the field of fatty liver disease. For example, Dr. Chalasani is the lead author of the multi-society practice guideline on the diagnosis and management of nonalcoholic fatty liver disease& Dr. Szabo is the president-elect of the American Association for the Study of Liver Disease which is the largest liver society in the world. They are also actively practicing clinicians and thus aware of clinically relevant knowledge gaps in the field.

Textul de pe ultima copertă

This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies.
Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.

Caracteristici

Combines coverage of both alcoholic and nonalcoholic fatty liver disease Includes the most up-to-date clinical information Volume editors are senior investigators in the fields of alcoholic and nonalcoholic fatty liver disease Chapters written by experts in the field Includes supplementary material: sn.pub/extras